FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway

Potthoff, Matthew J., Boney-Montoya, Jamie, Choi, Mihwa, He, Tianteng, Sunny, Nishanth E., Satapati, Santhosh, Suino-Powell, Kelly, Xu, H. Eric, Gerard, Robert D., Finck, Brian N., Burgess, Shawn C., Mangelsdorf, David J., Kliewer, Steven A.·2011·Cell Metabolism
DOI 10.1016/j.cmet.2011.03.019

Cited by (428)

Items 201–300 of 428

  1. Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies
    Daniel Jahn, Monika Rau, Julia Wohlfahrt, Heike M. Hermanns, Andreas Geier · 2016 · Digestive Diseases
  2. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
    Azin Vakilpour, Ehsan Amini‐Salehi, Arman Soltani Moghadam, Mohammad‐Hossein Keivanlou, Negin Letafatkar, Arman Habibi, Mohammad Hashemi, Negar Eslami, Reza Zare, Naeim Norouzi et al. · 2024 · Nutrition and Diabetes
  3. Endoplasmic Reticulum Stress in Aquaculture Species
    Noah Esmaeili, Christopher Joseph Martyniuk, Sunil Kadri, Hongyu Ma · 2025 · Reviews in Aquaculture
  4. The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease
    Stefano Fiorucci, Michele Biagioli, Monia Baldoni, Patrizia Ricci, Valentina Sepe, Angela Zampella, Eleonora Distrutti · 2021 · Expert Opinion on Drug Discovery
  5. Cysteine sulfinic acid decarboxylase regulation: A role for farnesoid X receptor and small heterodimer partner in murine hepatic taurine metabolism
    Thomas A. Kerr, Yuri Matsumoto, Hitoshi Matsumoto, Yan Xie, Lawrence L. Hirschberger, Martha H. Stipanuk, Sayeepriyadarshini Anakk, David D. Moore, 光博 渡辺, Susan Kennedy et al. · 2013 · Hepatology Research
  6. Intricate Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Isoforms in Normal Physiology and Disease
    Venu Seenappa, Manjunath Bandu Joshi, Kapaettu Satyamoorthy · 2019 · Current Molecular Medicine
  7. Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease
    Tim van Zutphen, Anna Bertolini, Hilde D. de Vries, Vincent W. Bloks, Jan Freark de Boer, Johan W. Jonker, Folkert Kuipers · 2019 · Handbook of experimental pharmacology
  8. Curtailing FGF19’s mitogenicity by suppressing its receptor dimerization ability
    Jianlou Niu, Jing Zhao, Jiamin Wu, Guanting Qiao, Junlian Gu, Chuanren Zhou, Qi Li, Ying Lei, Dezhong Wang, Huan Lin et al. · 2020 · Proceedings of the National Academy of Sciences
  9. FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in response to endoplasmic reticulum stress
    Makoto Shimizu, Juan Li, Ryuto Maruyama, Jun Inoue, Ryuichiro Sato · 2012 · Biochemical Journal
  10. Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance
    Nadejda Bozadjieva-Kramer, Jae Hoon Shin, Ziru Li, Alan C. Rupp, Nicole Miller, Stace Kernodle, Nicolas Lanthier, Paulina Henry, Nikhil Seshadri, Andriy Myronovych et al. · 2024 · JCI Insight
  11. The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications
    Zichen Luo, Wei Zhou, Tong Xie, Weichen Xu, Chen Shi, Zihan Xiao, Yu Si, Yan Ma, Qingling Ren, Liuqing Di et al. · 2024 · Acta Pharmaceutica Sinica B
  12. MECHANISMS IN ENDOCRINOLOGY: The gut–brain axis: regulating energy balance independent of food intake
    Rubén Nogueiras · 2021 · European Journal of Endocrinology
  13. Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice
    Xing Xian Yu, Lynnetta M. Watts, Vara Prasad Manchem, Kaushik Chakravarty, Brett P. Monia, Michael L. McCaleb, Sanjay Bhanot · 2013 · PLoS ONE
  14. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease
    Michele Biagioli, Silvia Marchianò, Cristina Di Giorgio, Martina Bordoni, Ginevra Urbani, Rachele Bellini, Carmen Massa, Rana Sami Ullah Khan, Rosalinda Roselli, Maria Chiara Monti et al. · 2023 · Biochemical Pharmacology
  15. Novel Strategies to Prevent Total Parenteral Nutrition‐Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes
    Eliana Lucchinetti, Phing‐How Lou, Paulina Wawrzyniak, Marcin Wawrzyniak, Michael M. Scharl, Gregory Holtzhauer, Stefanie D. Krämer, Martin Hersberger, Gerhard Rogler, Michael Zaugg · 2020 · Molecular Nutrition & Food Research
  16. Cholesteryl ester transfer protein protects against insulin resistance in obese female mice
    David A. Cappel, Brian T. Palmisano, Christopher H. Emfinger, Melissa N. Martinez, Owen P. McGuinness, John M. Stafford · 2013 · Molecular Metabolism
  17. β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice
    Emmanuel Somm, Hugues Henry, Stephen J. Bruce, Nicolas Bonnet, Sophie A. Montandon, Nicolas J. Niederländer, Andrea Messina, Sébastien Aeby, Marta Rosikiewicz, Lluís Fajas et al. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
  18. Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis
    Joanna Góralska, Urszula Raźny, Anna Polus, Agnieszka Dziewońska, Anna Gruca, Anna Zdzienicka, Aldona Dembinska-Kiec, Bogdan Solnica, Agnieszka Micek, Maria Kapusta et al. · 2020 · Nutrients
  19. FGF9 inhibits browning program of white adipocytes and associates with human obesity
    Yingkai Sun, Rui Wang, Shaoqian Zhao, Wen Li, Wen Liu, Lingyun Tang, Zhugang Wang, Weiqing Wang, Ruixin Liu, Guang Ning et al. · 2018 · Journal of Molecular Endocrinology
  20. Bile salt signaling and bile salt-based therapies in cardiometabolic disease
    Claire Groenen, Thuc-Anh Nguyen, Coen C. Paulusma, Stan F.J. van de Graaf · 2024 · Clinical Science
  21. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
    Makoto Shimizu, Ryuichiro Sato · 2022 · Cells
  22. Intermittent fasting induces rapid hepatocyte proliferation to restore the hepatostat in the mouse liver
    Abby Sarkar, Yinhua Jin, Brian C. DeFelice, Catriona Y. Logan, Yan Yang, Teni Anbarchian, Peng V. Wu, Maurizio Morri, Norma F Neff, Huy Nguyen et al. · 2022 · eLife
  23. Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells
    Zhi Yi Wan, Johann Shane Tian, Hayden Weng Siong Tan, Ai Lee Chow, Arthur Yi Loong Sim, Kenneth Hon-Kim Ban, Yun Chau Long · 2016 · Hepatology
  24. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption
    Shuai Li, Nan Wang, Xiaochen Guo, Junyan Li, Teng Zhang, Guiping Ren, Deshan Li · 2018 · Biomedicine & Pharmacotherapy
  25. Therapeutic utilities of fibroblast growth factor 19
    Xinle Wu, Yang Li · 2011 · Expert Opinion on Therapeutic Targets
  26. Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease
    Jacek Rysz, Anna Gluba-Brzózka, Dimitri P. Mikhailidis, Maciej Banach · 2015 · Expert Opinion on Investigational Drugs
  27. Ablation of liver Fxr results in an increased colonic mucus barrier in mice
    Noortje Ijssennagger, Kristel S. van Rooijen, Stefanía Magnúsdóttir, José M. Ramos Pittol, Ellen C.L. Willemsen, Marcel R. de Zoete, Matthijs J. D. Baars, Paul B. Stege, Carolina Colliva, Roberto Pellicciari et al. · 2021 · JHEP Reports
  28. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in db/db mice
    Ann Maria Kruse Hansen, Sara G. Vienberg, Kirsten Lykkegaard, Xin Zhao, Guo Tingqing, Dan Han, Xujia Zhang, Henning Thøgersen, Kristian Sass‐Ørum, Tina M. Tagmose et al. · 2018 · Biochemical Journal
  29. Bile acid signaling in MASLD: From pathogenesis to therapeutic applications
    Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner · 2025 · Hepatology
  30. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
    Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli · 2022 · Critical Reviews in Microbiology
  31. Regulation of bile acid homeostasis by the intestinal Diet1–FGF15/19 axis
    Karen Reue, Jessica M. Lee, Laurent Vergnes · 2014 · Current Opinion in Lipidology
  32. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism
    Marica Cariello, Marilidia Piglionica, Raffaella Maria Gadaleta, Antonio Moschetta · 2019 · Handbook of experimental pharmacology
  33. The role of FGF19 in metabolic regulation: insights from preclinical models to clinical trials
    Marcela Botelho de Carvalho, Gabriel Machado Chavez Passos Jorge, Luiza Wolf Zanardo, Leticia Miho Hamada, Larissa dos Santos Izabel, Sérgio Santoro, Juliana Magdalon · 2024 · American Journal of Physiology-Endocrinology and Metabolism
  34. Bile acids during pregnancy: Trimester variations and associations with glucose homeostasis
    Marianne Gagnon, Jocelyn Trottier, S. John Weisnagel, Claudia Gagnon, Anne‐Marie Carreau, Olivier Barbier, Anne‐Sophie Morisset · 2021 · Health Science Reports
  35. Selective Regulation of FGF19 and FGF21 Expression by Cellular and Nutritional Stress
    Makoto SHIMIZU, Hitomi MORIMOTO, Ryuto Maruyama, Jun Inoue, Ryuichiro Sato · 2015 · Journal of Nutritional Science and Vitaminology
  36. Petasin Activates AMP-Activated Protein Kinase and Modulates Glucose Metabolism
    Yusuke Adachi, Yayoi Kanbayashi, Ikue Harata, Risa Ubagai, Tetsuya Takimoto, Katsuya Suzuki, Tetsuya Miwa, Yasushi Noguchi · 2014 · Journal of Natural Products
  37. Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries
    Meng Wei, Yi Shao, Qiao-ran Liu, Qunzheng Wu, Xiang Zhang, Mingwei Zhong, Shao-zhuang Liu, Guangyong Zhang, Sanyuan Hu · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  38. Making Way for Suppressing the FGF19/FGFR4 Axis in Cancer
    Néstor Prieto‐Domínguez, Austin Young Shull, Yong Teng · 2018 · Future Medicinal Chemistry
  39. Differential effects of a 40-hour fast and bile acid supplementation on human GLP-1 and FGF19 responses
    F. Samuel van Nierop, Emma C. E. Meessen, Kyra G. M. Nelissen, Roos Achterbergh, Laureen A. Lammers, Frédéric Maxime Vaz, Ron A. A. Mathôt, Heinz‐Josef Klümpen, Steven W.M. Olde Damink, Frank G. Schaap et al. · 2019 · American Journal of Physiology-Endocrinology and Metabolism
  40. Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets
    Yi Chu, Su Yang, Xiaodong Chen · 2025 · Pharmacology & Therapeutics
  41. Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism
    Justine Gillard, Corinne Picalausa, Christoph Ullmer, Luciano Adorini, Bart Staels, Anne Tailleux, Isabelle Anne Leclercq · 2022 · Nutrients
  42. RISING STARS: Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome
    Rachel K. Meyer, Frank Anthony Duca · 2023 · Journal of Endocrinology
  43. Perfluoropolyether-Based Gut-Liver-on-a-Chip for the Evaluation of First-Pass Metabolism and Oral Bioavailability of Drugs
    Mengyang Wang, Yuko Sasaki, Rena Sakagami, Tomotaka Minamikawa, Masahiro Tsuda, Ryohei Ueno, Sayaka Deguchi, Ryosuke Negoro, Kanako So, Yuriko Higuchi et al. · 2024 · ACS Biomaterials Science & Engineering
  44. Bile acids as metabolic regulators: an update
    Tiangang Li, John Y.L. Chiang · 2023 · Current Opinion in Gastroenterology
  45. Serum Fibroblast Growth Factor 19 and Total Bile Acid Concentrations Are Potential Biomarkers of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus
    Yi Xin Sun, Minxia Zhu, Hui Zhao, Xiaoqing Ni, Renan Chang, Jianyou Su, Hua Huang, Shiwei Cui, Xinlei Wang, Jin Yuan et al. · 2020 · BioMed Research International
  46. Effect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis
    Paul MacDaragh Ryan, Nathaniel Edward Hayward, Ryan Taylor Sless, Philip Garwood, Jamal Rahmani · 2020 · Obesity Reviews
  47. FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis
    Yingquan Wen, Zi-Yuan Zou, Guanguan Zhao, Mengjiao Zhang, Yongxin Zhang, Gaihong Wang, Jingjing Shi, Yuan-Yang Wang, Ye-Yu Song, Huixia Wang et al. · 2024 · Acta Pharmacologica Sinica
  48. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta‐analysis
    Anne‐Sofie Houlberg Jensen, Marie Winther‐Sørensen, Johan M. Burisch, Annika M Bergquist, Henriette Ytting, Lise Lotte Gluud, Nicolai J. Wewer Albrechtsen · 2023 · Liver International
  49. The effects of metformin on fibroblast growth factor 19, 21 and fibroblast growth factor receptor 1 in high-fat diet and streptozotocin induced diabetic rats
    Yan Wang, Ningning Dang, Pei Sun, Jin Xia, Chunxue Zhang, Shuguang Pang · 2017 · Endocrine Journal
  50. Liver–gut axis signaling regulates circadian energy metabolism in shift workers
    Zhenning Yang, Helmut Zarbl, Bo Kong, Rulaiha E. Taylor, Kathleen Black, Howard M. Kipen, Veronia Basaly, Mingzhu Fang, Grace Liejun Guo · 2024 · The FASEB Journal
  51. FGF15/FGFR4 signaling suppresses M1 macrophage polarization and multi-organ inflammation in septic mice by inhibiting H3K18 lactylation-driven Irf7 expression through NF2-Hippo activation
    Bo Li, Jia-yu Li, Zexiang Zhu, Yong Tang, Yun Zhou, Geshu Du, Xing Li · 2025 · Cell Death and Disease
  52. Fibroblast growth factor 19 improves cardiac function and mitochondrial energy homoeostasis in the diabetic heart
    Wei Xu, Yongshun Wang, Yibo Guo, Jingjin Liu, Lijia Ma, Wei Cao, Bo Yu, Yuhong Zhou · 2018 · Biochemical and Biophysical Research Communications
  53. Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications
    Hirofumi Okubo, Akifumi Kushiyama, Yusuke Nakatsu, Takeshi Yamamotoya, Yasuka Matsunaga, Midori Fujishiro, Hideyuki Sakoda, Haruya Ohno, Masayasu Yoneda, Tomoichiro Asano · 2018 · International Journal of Molecular Sciences
  54. Gut microbiota, bile acids, and nature compounds
    Hao Cheng, Juan Liu, Dandan Zhang, Yuzhu Tan, Wuwen Feng, Cheng Peng · 2022 · Phytotherapy Research
  55. Endocrine Adiponectin‐FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury
    Min You, Zhou Zhou, Michael J. Daniels, Alvin P. Jogasuria · 2017 · Gene Expression
  56. Ostα−/−mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity
    Sadie G. Wheeler, Christine L. Hammond, François R. Jornayvaz, Varman T. Samuel, Gerald I. Shulman, Carol J. Soroka, James Lorenzen Boyer, Patricia M. Hinkle, Nazzareno Ballatori · 2014 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  57. Bile acid receptors link nutrient sensing to metabolic regulation
    Jibiao Li, Tiangang Li · 2017 · Liver Research
  58. Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner
    Jia-Lu Zhang, Hongtao Li, N. Bai, Yu Xu, Q. Song, L. Zhang, Guangyu Wu, S. Chen, Xuhong Hou, Congrong Wang et al. · 2019 · Journal of Endocrinological Investigation
  59. Gut microbiota is a factor of risk for obesity and type 2 diabetes
    Tatiana Yu. Demidova, Лобанова Кристина Геннадьевна, О Ш Ойноткинова · 2020 · Terapevticheskii arkhiv
  60. Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation
    Qi Li, Wanlin Dai, Jing Kong, Yu Tian, Yongsheng Chen · 2021 · Journal of Physiology and Biochemistry
  61. Chlorhexidine-containing chewing gum. Clinical documentation
    Thomas N. Imfeld · 2006 · PubMed
  62. FGF15/FGF19 alleviates insulin resistance and upregulates placental IRS1/GLUT expression in pregnant mice fed a high-fat diet
    Shanshan Zhao, Dongyu Wang, Zhuyu Li, Shuqia Xu, Haitian Chen, Wenjing Ding, Juan Yang, Weihua Zhao, Bo Sun, Zilian Wang · 2021 · Placenta
  63. Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
    H. Bays · 2014 · International Journal of General Medicine
  64. Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation
    Dasheng Lu, Yameng Liu, Yuhong Luo, Jie Zhao, Chao Feng, Liming Xue, Jiale Xu, Qiong Wang, Tingting Yan, Ping Xiao et al. · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  65. FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels
    Quan Shang, Grace Liejun Guo, Akira Honda, Monica Saumoy, Gerald Salen, Guorong Xu · 2013 · Journal of Lipid Research
  66. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study
    Emma Rose McGlone, Khalefah Malallah, Joyceline Cuenco, Nicolai J. Wewer Albrechtsen, Jens Juul Holst, Royce P Vincent, Charlotte Ling, Omar A Khan, Surabhi Verma, Ahmed R. Ahmed et al. · 2021 · American Journal of Physiology-Endocrinology and Metabolism
  67. PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol
    Devina Mehta, Kamal D. Mehta · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  68. Live-Cell FRET Imaging Reveals a Role of Extracellular Signal-Regulated Kinase Activity Dynamics in Thymocyte Motility
    Yoshinobu Konishi, Kenta Terai, Yasuhide Furuta, Hiroshi Kiyonari, Takaya Abe, Yoshihiro Ueda, Tatsuo Kinashi, Yoko Hamazaki, Akifumi Takaori‐Kondo, Michiyuki Matsuda · 2018 · iScience
  69. Regulation of Fgf15 expression in the intestine by glucocorticoid receptor
    Kunzhi Jia, Danping Zhang, Qi Jia, Qing‑Yu Zhang · 2019 · Molecular Medicine Reports
  70. Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients
    Kiran V.K. Koelfat, Mark Philip Plummer, Frank G. Schaap, Martin Leníček, Peter L. M. Jansen, Adam M. Deane, Steven W.M. Olde Damink · 2019 · Hepatology
  71. The Physiological Importance of Bile Acid Structure and Composition on Glucose Homeostasis
    Sei Higuchi · 2020 · Current Diabetes Reports
  72. Reduced glycodeoxycholic acid levels are associated with negative clinical outcomes of gestational diabetes mellitus
    Bo Zhu, Zhixin Ma, Yuning Zhu, Lei Fang, Hong Zhang, Hongwei Kong, Dajing Xia · 2021 · Journal of Zhejiang University SCIENCE B
  73. Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
    Alexandru Niţă, Sara P. Abraham, Pavel Krejčı́, Michaela Kunova Bosakova · 2021 · Cells
  74. Mouse models of nonalcoholic steatohepatitis and their application to new drug development
    Huy Hieu Phung, Chang Hoon Lee · 2022 · Archives of Pharmacal Research
  75. Differential Effects of One Meal per Day in the Evening on Metabolic Health and Physical Performance in Lean Individuals
    Meessen, Emma C. E., Andresen, Håvard, van Barneveld, Thomas, van Riel, Anne, Johansen, Egil I., Kolnes, Anders J., Kemper, E. Marleen, Olde Damink, Steven W. M., Schaap, Frank G., Romijn, Johannes A. et al. · 2022 · Frontiers in Physiology
  76. β-Klotho as novel therapeutic target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A narrative review
    Marica Meroni, Paola Dongiovanni, Francesca Tiano, Roberto Piciotti, Anna Alisi, Nadia Panera · 2024 · Biomedicine & Pharmacotherapy
  77. The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome
    Shuqi Pu, Xiaojie Wu, Xiaoying Yang, Yunzhan Zhang, Yunkai Dai, Yueling Zhang, Xiaoting Wu, Yan Liu, Xiaona Cui, Haiyong Jin et al. · 2018 · Current Drug Metabolism
  78. Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome
    Nienke van Olst, Suzanne Meiring, Maurits de Brauw, Jacques J.G.H.M. Bergman, Max Nieuwdorp, Donald Leonard van der Peet, Victor E. A. Gerdes · 2020 · Techniques and Innovations in Gastrointestinal Endoscopy
  79. Advances in FGFs for diabetes care applications
    Yinai Liu, Qianqian Chen, Yaoqi Li, Liuliu Bi, Zhiying He, Chuxiao Shao, Libo Jin, Renyi Peng, Xingxing Zhang · 2022 · Life Sciences
  80. The New Markers of Early Obesity-Related Organ and Metabolic Abnormalities
    Agata Ziomber-Lisiak, Kaja Piana, Beata Ostachowicz, Paweł Wróbel, Paula Kasprzyk, Jolanta Kaszuba-Zwoińska, Agnieszka Baranowska-Chowaniec, Kajetan Juszczak, Magdalena Szczerbowska‐Boruchowska · 2022 · International Journal of Molecular Sciences
  81. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A
    Daniel Jahn, D. Sutor, Donata Dorbath, Johannes Weiß, Oliver Götze, Johannes Schmitt, Heike M. Hermanns, Andreas Geier · 2015 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  82. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease
    Yuichiro Kondo, Hirotaka Komaba, Masafumi Fukagawa · 2020 · Expert Review of Molecular Diagnostics
  83. Knock-in Luciferase Reporter Mice for In Vivo Monitoring of CREB Activity
    Dmitry Akhmedov, Kavitha Rajendran, Maria G. Mendoza‐Rodriguez, Rebecca Berdeaux · 2016 · PLoS ONE
  84. FGF family in health and disease
    Xiaoyu Liu, Meiling Jing, Yueyi Yang, Qiaoqiao Jin, Bo Feng, Pengfei Zhang, Chenguang Niu, Xuchen Hu, Zhengwei Huang · 2026 · Molecular Biomedicine
  85. Effects of crustacean hyperglycaemic hormone RNA interference on regulation of glucose metabolism in Litopenaeus vannamei after ammonia-nitrogen exposure
    Xin Zhang, Luqing Pan, Ruixue Tong, Yufen Li, Lingjun Si, Yuanjing Chen, Manni Wu, Qiaoqiao Wang · 2021 · British Journal Of Nutrition
  86. The contributions of bacteria metabolites to the development of hepatic encephalopathy
    Miranda Claire Gilbert, Tahereh Setayesh, Yu‐Jui Yvonne Wan · 2022 · Liver Research
  87. Glycodeoxycholic Acid Inhibits Primary Bile Acid Synthesis With Minor Effects on Glucose and Lipid Homeostasis in Humans
    Emma C. E. Meessen, Soumia Majait, Ümran Ay, Steven W.M. Olde Damink, Johannes Anthonius Romijn, Jens Juul Holst, Bolette Hartmann, Folkert Kuipers, Max Nieuwdorp, Frank G. Schaap et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
  88. An Atlas of Inter-Organ Metabolite Trafficking in Health and Atherogenic Conditions
    Hosung Bae, Sunhee Jung, Johnny Le, Ian J. Tamburini, Joo‐Hwan Kim, Eric Wang, Won-Suk Song, Wonsuk Choi, Ki-Hong Jang, Taekyung Kang et al. · 2024 · Cell
  89. Diet1 Is a Regulator of Fibroblast Growth Factor 15/19-Dependent Bile Acid Synthesis
    Karen Reue, Jessica M. Lee, Laurent Vergnes · 2015 · Digestive Diseases
  90. Mechanism of bile acid-regulated glucose and lipid metabolism in duodenal-jejunal bypass.
    Jie Chai, Lei Zou, Xirui Li, Dali Han, Shan Wang, Sanyuan Hu, Jie Guan · 2015 · PubMed Central
  91. Vitamin D regulates glucose metabolism in zebrafish (Danio rerio) by maintaining intestinal homeostasis
    Rui Shao, Xinmeng Liao, Wentao Wang, Yawen Lan, Hui Zhang, Qingyang Du, Lin Jiao, Zhan Yin, Qinghui Ai, Kangsen Mai et al. · 2023 · The Journal of Nutritional Biochemistry
  92. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
    Lucas Zangerolamo, Marina Uchôa Wall Barbosa De Carvalho, Licio Augusto Velloso, Helena C.L. Barbosa · 2023 · European Journal of Pharmacology
  93. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose
    Jing Zhang, Huating Li, Hu Zhou, Li Fang, Jingjing Xu, Han Yan, Shuqin Chen, Qianqian Song, Yinan Zhang, Aimin Xu et al. · 2017 · Scientific Reports
  94. Role of fibroblast growth factor 19 in maintaining nutrient homeostasis and disease.
    Jing Zhang, Hua Ting Li, Qi Chen Fang, Wei Jia · 2014 · PubMed
  95. Deep Sequencing of Plasma Exosomal microRNA Level in Psoriasis Vulgaris Patients
    Xiumin Chen, Danni Yao, Maojie Wang, Xiaodong Wu, Jingwen Deng, Hao Deng, Runyue Huang, Chuanjian Lu · 2022 · Frontiers in Medicine
  96. Interaction of Klotho and sirtuins
    Farzaneh Rostamzadeh, Yasamin Moosavi-Saeed, Mahboobeh Yeganeh‐Hajahmadi · 2023 · Experimental Gerontology
  97. Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy men
    Emma C. E. Meessen, Guido J. Bakker, Max Nieuwdorp, Geesje M. Dallinga‐Thie, Elles Marleen Kemper, Steven W.M. Olde Damink, Johannes Anthonius Romijn, Bolette Hartmann, Jens Juul Holst, Filip Krag Knop et al. · 2020 · Clinical Nutrition
  98. Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry
    Yan Gu, Peng Zang, Jinxia Li, Yanyan Yan, Jia Wang · 2022 · Chinese Journal of Chromatography
  99. The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
    Agata Sadowska, Elżbieta Poniedziałek‐Czajkowska, Radzisław Mierzyński · 2023 · International Journal of Molecular Sciences
  100. The role of gut dysbiosis and mitochondrial dysfunction in type 2 diabetes: Insights on pathogenesis, intervention and future perspective
    Xuefei Yu, Mingxiao Li, Houkai Li · 2025 · Biomedicine & Pharmacotherapy